Daehan Nupharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	93,615	96,422	127,019	119,861	152,985	176,845
Market Cap Growth	-8.00%	-24.09%	5.97%	-21.65%	-13.49%	21.15%
Enterprise Value	157,152	114,707	125,867	131,114	172,368	194,665
Last Close Price	6670.00	6766.22	8786.32	8199.26	10348.04	11876.51
PE Ratio	8.61	6.23	10.13	4.93	9.75	-
PS Ratio	0.46	0.48	0.62	0.61	0.92	1.19
PB Ratio	0.72	0.77	1.16	1.16	1.86	2.99
P/TBV Ratio	0.73	0.78	1.17	1.17	1.87	3.00
P/FCF Ratio	-	-	44.89	11.08	25.68	43.32
P/OCF Ratio	9.85	5.09	10.11	8.41	9.23	13.06
EV/Sales Ratio	0.78	0.57	0.62	0.66	1.03	1.30
EV/EBITDA Ratio	9.36	5.04	5.63	4.21	5.80	7.41
EV/EBIT Ratio	12.51	6.15	6.67	4.69	6.53	8.38
EV/FCF Ratio	-3.63	-	44.48	12.12	28.93	47.69
Debt / Equity Ratio	0.73	0.47	0.34	0.36	0.45	0.66
Debt / EBITDA Ratio	5.44	2.61	1.64	1.18	1.24	1.49
Debt / FCF Ratio	-	-	12.93	3.39	6.20	9.60
Net Debt / Equity Ratio	0.49	0.18	0.12	0.07	0.18	0.30
Net Debt / EBITDA Ratio	3.65	0.96	0.57	0.23	0.49	0.69
Net Debt / FCF Ratio	-1.47	-1.56	4.53	0.67	2.45	4.41
Asset Turnover	0.88	1.01	1.18	1.21	1.15	1.15
Inventory Turnover	2.95	3.04	3.54	4.30	4.83	5.42
Quick Ratio	1.04	1.06	1.01	1.11	1.16	1.00
Current Ratio	1.61	1.61	1.60	1.75	1.69	1.34
Return on Equity (ROE)	8.57%	13.18%	11.81%	26.23%	22.15%	-16.82%
Return on Assets (ROA)	3.59%	5.86%	6.81%	10.68%	11.36%	11.15%
Return on Invested Capital (ROIC)	5.56%	11.66%	9.84%	19.00%	20.15%	29.57%
Return on Capital Employed (ROCE)	7.20%	12.50%	16.40%	25.20%	23.40%	28.50%
Earnings Yield	11.62%	16.04%	9.87%	20.29%	10.26%	-5.72%
FCF Yield	-46.20%	-14.61%	2.23%	9.03%	3.90%	2.31%
Payout Ratio	12.90%	9.07%	11.19%	4.62%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.